The field of Medicines Development faces a continuous need for educational evolution
to match the interdisciplinary and global nature of the pharmaceutical industry. This
paper discusses the outcomes of a 7-year collaboration between King's College London
and the Global Medicines Development Professionals (GMDP) Academy, which aimed to
address this need through a blended e-learning program.The collaboration developed
a comprehensive curriculum based on the PharmaTrain syllabus, delivered through a
combination of asynchronous and synchronous e-learning methods. The program targeted
a diverse range of professionals serving in areas related to Medical Affairs.Over
seven annual cohorts, 682 participants from eighty-six countries were enrolled in
the program. The program's effectiveness was assessed using Kirkpatrick's model, showing
elevated levels of satisfaction (over 4.0 on a five-point scale), suggesting significant
gains in competence at the cognitive level and leveraged performance. Notably, 70%
of responding alumni reported significant improvement in their functions, corroborated
by 30% of their supervisors. The further long-term impact of the program on their
respective organization has not been established.The GMDP Academy's program has significantly
contributed to life-long learning in Medicines Development, addressing educational
gaps and fostering interdisciplinary collaboration. Its success highlights the importance
of continuous education in keeping pace with the industry's evolving demands and underscores
the potential of blended learning in achieving educational objectives in pharmaceutical
medicine.
